US Bancorp’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-243,748
Closed -$51.8M 3778
2014
Q4
$51.8M Sell
243,748
-21,367
-8% -$4.25M 0.2% 109
2014
Q3
$47.2M Sell
265,115
-4,121
-2% -$684K 0.19% 114
2014
Q2
$45.6M Sell
269,236
-16,817
-6% -$2.62M 0.18% 118
2014
Q1
$35.5M Buy
286,053
+23,870
+9% +$2.91M 0.15% 133
2013
Q4
$29.1M Sell
262,183
-3,610
-1% -$345K 0.12% 151
2013
Q3
$24M Sell
265,793
-51,912
-16% -$4.66M 0.11% 159
2013
Q2
$26.8M Buy
+317,705
New +$33M 0.12% 144

Other funds holding AGN

US Bancorp's AGN Position: Q1 2015 in Review

US Bancorp sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 243,748 shares — an estimated $51.8M sold.

US Bancorp first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $51.8M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • US Bancorp reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • US Bancorp sold 243,748 Allergan Inc shares in Q1 2015, an estimated $51.8M.
  • US Bancorp first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • US Bancorp's Allergan Inc position peaked at $51.8M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on US Bancorp's 13F filing for Q1 2015, filed 8 May 2015.